Related references
Note: Only part of the references are listed.Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily
Eleni Gavriilaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19
Mario Enrico Canonico et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)